About Aesica
Aesica is a company based in Newcastle Upon Tyne (United Kingdom) founded in 2004 was acquired by Pharmaron in January 2023. Aesica has completed 1 acquisition, including R5 Pharmaceuticals. Aesica operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Newcastle Upon Tyne, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmaron Manufacturing Services (Uk) Ltd
- Date of Incorporation 23 Jul, 2004
- Jurisdiction CRAMLINGTON, NORTHUMBERLAND, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Pharmaron
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Aesica
Unlock access to complete
Unlock access to complete
Software Development Team
71 people
Leadership Team
17 people
Human Resources and Administration
17 people
Sales and Marketing
13 people
Head Team
13 people
Finance and Accounting
9 people
Operations Team
6 people
Product Management Team
6 people
Unlock access to complete
Funding Insights of Aesica
Detailed funding history for Aesica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aesica
Aesica has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pharmaron and Consort Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Portfolio of products for airway management and drug delivery
|
Locked | Locked | Locked | |
|
Drug discovery and development services for small molecules are provided.
|
Locked | Locked | Locked |
Investor details for Aesica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aesica
Aesica has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include R5 Pharmaceuticals.
Investment portfolio details for Aesica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops formulations for clinical trials ranging from solid-dose capsules to liquids and injectables
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Aesica
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aesica
Detailed financials for Aesica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aesica Comparisons
Peer comparison for Aesica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aesica
Aesica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Aesica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aesica
Complete news archive for Aesica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aesica
Aesica was founded in 2004.
Aesica is headquartered in Newcastle Upon Tyne, United Kingdom.
Manja Boerman is the current CEO of Aesica.
Aesica is a pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dose forms.It offers end-to-end pharmaceutical development and manufacturing solution that comprises of capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.it also offers end-to-end capabilities in the design, industrialization and manufacture of medical delivery device. Recently, the company won young achiever of the year chemical industry award.
Aesica's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Aesica has made 1 acquisition, including R5 Pharmaceuticals.
Aesica has 2 investors. Key investors include Pharmaron, and Consort Medical.